Galadlas, Carmelight E.
HRN: 23-53-42 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/11/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
01/11/2025
01/18/2025
IV
300 Mg
Q6hrs
PCAP-C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes